Polpharma Pharmaceutical Works - API Manufacturer

drukuj

Current API product portfolio   

Piracetam

Specification:
  • Ph.Eur.
chemical name: 2-oxo-1-pyrrolidineacetamide
molecular formula: C6H10N2O2
structural formula: structural formula
molecular weight: 142.15
CAS Registery number: 7491-74-9

General information:

Appearance: white or almost white, crystalline powder.
Solubility: freely soluble in water, soluble in ethanol (96 per cent).
It shows polymorphism.

TESTS REQUIERMENTS METHODS
Identification:

A. IR spectrum


comparison with reference substance spectrum
Ph. Eur.
Appearance of solution clear and colouress Ph. Eur.
Related substances:

- pyrrolidin-2-one (A impurity)

- methyl (2-oxopyrrolidin-1-yl)acetate (B impurity)

- ethyl (2-oxopyrrolidin-1-yl)acetate (C impurity)

- (2-oxopyrrolidin-1-yl)acetic acid (D impurity)

- other single unspecified impurity

- total impurities



not more than 0.1%

not more than 0.1%


not more than 0.1%


not more than 0.1%


not more than 0.10%

not more than 0.3%
Ph. Eur.
Heavy metals not more than 10 ppm Ph. Eur.
Loss on drying not more than 1.0% Ph. Eur.
Sulphated ash not more than 0.1% Ph. Eur.
Content of piracetam calculated on dried substance 98.0% - 102.0% Ph. Eur.
Residual solvents:

- methanol

- acetone

- toluene


not more than 300 ppm

not more than 100 ppm

not more than 50 ppm
POLPHARMA
« back to API list

Latest news

CEP for Baclofen available

Monday, 02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of...

Polpharma – the most innovative company in Poland

Friday, 20-05-2011
Polpharma ranked first as the most innovative company in Poland, in a research study run by the Institute...

Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex

Friday, 08-10-2010
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex for the...

Co-operation between Polpharma and RPG Life Sciences

Tuesday, 05-10-2010
RPGLS and Polpharma announced their co-operation in the development and manufacture of Active...
© POLPHARMA S.A. All rights reserved.
Realizacja: Ideo